Last reviewed · How we verify
NCT04381780
Treatment of Fibromyalgia With Recovery Factors
NA trial testing Recovery Factors in Fibromyalgia in 100 participants. Completed in 15 January 2021.
1 December 2020
Quick facts
| Lead sponsor | Practitioners Alliance Network |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 6 May 2020 |
| Primary completion | 1 December 2020 |
| Estimated completion | 15 January 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Recovery Factors
Conditions studied
- Fibromyalgia — all drugs for Fibromyalgia →
- Chronic Fatigue Syndrome — all drugs for Chronic Fatigue Syndrome →
Sponsor
Practitioners Alliance Network
Who can join
18 and older, any sex, with Fibromyalgia or Chronic Fatigue Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Treatment of Fibromyalgia and CFS with Recovery Factors
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04381780
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Recovery Factors
Trials testing the same drug.
- NCT04381793 — Treatment of CFS & Fibromyalgia With Recovery Factors · NA · completed
Other recruiting trials for Fibromyalgia
Currently open trials in the same condition.
- NCT02285868 — ATI Evidence-based Guide Investigating Clinical Services · active not recruiting
- NCT07245303 — Neural Mechanisms of Light Driven Analgesia · NA · recruiting
- NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
- NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
- NCT07465991 — The Effect of Digital Cognitive Behavioural Therapy for Insomnia on Physical Activity in Fibromyalgia · NA · recruiting
Other Practitioners Alliance Network trials
Trials by the same sponsor.
- NCT04599348 — Treatment of CFS and Fibromyalgia With HRG 80 Red Ginseng · EARLY_PHASE1 · unknown
- NCT04598243 — Treatment of Fibromyalgia and CFS With Ribose, Ashwagandha, Rhodiola, Licorice, Schisandra and Green Tea Extract · EARLY_PHASE1 · unknown
- NCT04381793 — Treatment of CFS & Fibromyalgia With Recovery Factors · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04381780 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Practitioners Alliance Network
- Last refreshed: 11 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04381780.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing